Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Pryor (Apalutamide) 60mg Tablets
Pryor (Apalutamide) 60mg Tablets, manufactured by Zydus Cadila, is a specialized medication indicated for the treatment of prostate cancer, providing targeted therapy to inhibit cancer cell growth.
Uses of Pryor (Apalutamide) 60mg Tablets
Pryor (Apalutamide) 60mg Tablets are used for:
Treatment of non-metastatic castration-resistant prostate cancer (nmCRPC).
Administration in combination with androgen deprivation therapy (ADT) for metastatic castration-sensitive prostate cancer (mCSPC).
Benefits of Pryor (Apalutamide) 60mg Tablets
Delays disease progression and prolongs metastasis-free survival in prostate cancer patients.
Reduces the risk of cancer spread and improves overall survival outcomes.
Offers a convenient oral formulation, enhancing patient adherence and quality of life during treatment.
Mechanism of Action of Pryor (Apalutamide) 60mg Tablets
Pryor (Apalutamide) 60mg Tablets contain apalutamide, a next-generation androgen receptor inhibitor. It competitively inhibits androgen binding and impairs androgen receptor translocation, thereby blocking androgen receptor signaling. This mechanism suppresses prostate cancer cell growth and promotes cancer regression.